Karen G. Corraini - Net Worth and Insider Trading
Karen G. Corraini Net Worth
The estimated net worth of Karen G. Corraini is at least $92,565 dollars as of 2024-11-10. Karen G. Corraini is the See Remarks of Xenon Pharmaceuticals Inc and owns about 2,057 shares of Xenon Pharmaceuticals Inc (XENE) stock worth over $92,565. Details can be seen in Karen G. Corraini's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Karen G. Corraini has not made any transactions after 2014-11-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Karen G. Corraini
Karen G. Corraini Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Karen G. Corraini owns 1 companies in total, including Xenon Pharmaceuticals Inc (XENE) .
Click here to see the complete history of Karen G. Corraini’s form 4 insider trades.
Insider Ownership Summary of Karen G. Corraini
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2015-03-17 | Gen. Counsel & Corp. Secretary |
Karen G. Corraini Latest Holdings Summary
Karen G. Corraini currently owns a total of 1 stock. Karen G. Corraini owns 2,057 shares of Xenon Pharmaceuticals Inc (XENE) as of November 4, 2014, with a value of $92,565.
Latest Holdings of Karen G. Corraini
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2014-11-04 | 2,057 | 45.00 | 92,565 |
Holding Weightings of Karen G. Corraini
Karen G. Corraini Form 4 Trading Tracker
According to the SEC Form 4 filings, Karen G. Corraini has made a total of 0 transactions in Xenon Pharmaceuticals Inc (XENE) over the past 5 years. The most-recent trade in Xenon Pharmaceuticals Inc is the sale of 0 shares on November 4, 2014, which brought Karen G. Corraini around $0.
Insider Trading History of Karen G. Corraini
- 1
Karen G. Corraini Trading Performance
Karen G. Corraini Ownership Network
Ownership Network List of Karen G. Corraini
Ownership Network Relation of Karen G. Corraini
Karen G. Corraini Owned Company Details
What does Xenon Pharmaceuticals Inc do?
Who are the key executives at Xenon Pharmaceuticals Inc?
Karen G. Corraini is the Gen. Counsel & Corp. Secretary of Xenon Pharmaceuticals Inc. Other key executives at Xenon Pharmaceuticals Inc include SVP Bus. & Corp. Development Sherrington Robin , director & PRESIDENT & CEO Ian Mortimer , and Chief Medical Officer Christopher John Kenney .
Xenon Pharmaceuticals Inc (XENE) Insider Trades Summary
Over the past 18 months, Karen G. Corraini made no insider transaction in Xenon Pharmaceuticals Inc (XENE). Other recent insider transactions involving Xenon Pharmaceuticals Inc (XENE) include a net sale of 26,576 shares made by Gary Patou , a net sale of 131,245 shares made by Simon N. Pimstone , and a net sale of 31,655 shares made by Ian Mortimer .
In summary, during the past 3 months, insiders sold 0 shares of Xenon Pharmaceuticals Inc (XENE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 236,705 shares of Xenon Pharmaceuticals Inc (XENE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 236,705 shares.
Xenon Pharmaceuticals Inc (XENE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xenon Pharmaceuticals Inc Insider Transactions
Karen G. Corraini Mailing Address
Above is the net worth, insider trading, and ownership report for Karen G. Corraini. You might contact Karen G. Corraini via mailing address: C/o Xenon Pharmaceuticals Inc., 200 - 3650 Gilmore Way, Burnaby A1 V5g4w8.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
